By contrast, in an APP/PS1 model of AD, STAT3 deficient animals showed reduced β-amyloid levels and plaque burden, decreased pro-inflammatory cytokines, and rescued memory decline. This evidence concerns the gene STAT3 and Alzheimer disease.